Wetenschappelijke publicaties
In vitro tailoring of regulatory T cells prior to cell therapy
Baeten P., Hellings N., Broux B.
Nov.
2020
Trends in Molecular Medicine
Isolated regulatory T cells (Tregs) are expanded in vitro using anti-CD3/anti-CD28 beads (activation/proliferation) and IL-2 (survival). Polyclonal Tregs are reintroduced into patients safely in graft-versus-host disease (GvHD), transplantation rejection, and type 1 diabetes mellitus (T1DM) clinical trials. The expansion step provides a window of opportunity for in vitro Treg manipulation to boost their function and stability, which are impaired in autoimmunity.
Blijven op de hoogte gebracht
Ontvang alle informatie met betrekking tot onderzoek en nieuws van de Charcot Foundation rechtstreeks in je inbox.
Door op "Ik schrijf me in" te klikken, aanvaardt u ons privacybeleid.
